Abstract
Modern biotechnology techniques with focus on RNA and protein gene expression have fundamentally altered our view of the pathogenesis of neurological diseases, in general, and HIV-associated neurocognitive disorders (HAND), in particular. Extensive analysis of gene expression enables scientists to assess the simultaneous expression modes of enormous groups of genes. The alterations in adjustment and expression modes of these genes in relation to pathophysiology of NeuroAIDS and HAND provide us with crucial clues into molecular mechanisms of development of AIDS invasion to and infection of human nervous system and how such a vast process affects different tissues within the peripheral immune system and the nervous system. The present chapter focuses on the latest findings in gene expression patterns during pathophysiology of HAND with emphasis on their potential application for treatment of these patients. Specifically, through this chapter we concentrate on the gene expression by the cells within the central nervous system (CNS), neurons, astrocytes, and oligodendrocytes during pathogenesis of HAND.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Haddow LJ, Cartledge JD, Manji H (2013) HIV and the brain: from AIDS to old age. Clin Med (Lond) 13(Suppl 6):s24–s28
Brew BJ, Chan P (2014) Update on HIV dementia and HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep 14(8):468
Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neuro-Oncol 8(Suppl 2):115–121
Levine AJ, Miller JA, Shapshak P, Gelman B, Singer EJ, Hinkin CH, Commins D, Morgello S, Grant I, Horvath S (2013) Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer’s disease. BMC Med Genet 6:4. doi:10.1186/1755-8794-6-4
Yelamanchili SV, Chaudhuri AD, Chen LN, Xiong H, Fox HS (2010) MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis 1:e77. doi:10.1038/cddis.2010.56
Repunte-Canonigo V, Lefebvre C, George O, Kawamura T, Morales M, Koob GF, Califano A, Masliah E, Sanna PP (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener 9:26. doi:10.1186/1750-1326-9-26
Siangphoe U, Archer KJ (2015) Gene expression in HIV-associated neurocognitive disorders: a meta-analysis. J Acquir Immune Defic Syndr 70(5):479–488
Jing T, Wu L, Borgmann K, Surendran S, Ghorpade A et al (2010) Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration. Biochem Biophys Res Commun 402:241–246
Brack-Werner R (1999) Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13:1–22
Boven LA, Vergnolle N, Henry SD, Silva C, Imai Y et al (2003) Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol 170:2638–2646
Dou H, Morehead J, Bradley J, Gorantla S, Ellison B et al (2006) Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain. Glia 54:81–93
El-Hage N, Podhaizer EM, Sturgill J, Hauser KF (2011) Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 tat, gp120, and morphine. Immunol Investig 40(5):498–522
Patton HK, Zhou ZH, Bubien JK, Benveniste EN, Benos DJ (2000) gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux. Am J Phys Cell Phys 279(3):C700–C708
Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312(1):60–73
Bezzi P, Domercq M, Brambilla L, Galli R, Schols D et al (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702–710
Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391(6664):281–285
Verkhratsky A, Rodríguez JJ, Parpura V (2013) Astroglia in neurological diseases. Future Neurol 8:149–158
Zhou BY, Liu Y, Bo K, Xiao Y, He JJ (2004) Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci 27:296–305
Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and Neurodegeneration reconsidered. Curr HIV/AIDS Rep 12(2):272–279
Sofroniew MV, Vinters HV (2010 Jan) Astrocytes: biology and pathology. Acta Neuropathol 119(1):7–35
Yang Z, Wang KK (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 38(6):364–374
Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C, Ghorpade A (2005) Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox Res 7(3):183–192
Reddy PV, Gandhi N, Samikkannu T, Saiyed Z, Agudelo M et al (2012) HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder. Neurochem Int 61:807–814
Shah A, Verma AS, Patel KH, Noel R, Rivera-Amill V et al (2011) HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS One 6:e21261
Shah A, Kumar A (2010) HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA. J Neuroinflammation 7:96
Shah A, Singh DP, Buch S, Kumar A (2011) HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway. Biochem Biophys Res Commun 414:112–117
Borjabad A, Brooks AI, Volsky DJ (2010) Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5(1):44–62
Jayadev S, Yun B, Nguyen H, Yokoo H, Morrison RS, Garden GA (2007 Dec) The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. J Neuroimmune Pharmacol 2(4):359–370
Atluri VS, Kanthikeel SP, Reddy PV, Yndart A, Nair MP (2013) Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One 8(4):e61399
Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, González-Scarano F (1996) HIV-1 infection of cultured human adult oligodendrocytes. Virology 217(1):211–219
Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R et al (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573–585
Nuovo GJ, Becker J, Burk MW, Margiotta M, Fuhrer J, Steigbigel RT (1994) In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr 7:916–923
Ensoli F, Cafaro A, Fiorelli V, Vannelli B, Ensoli B, Thiele CJ (1995) HIV-1 infection of primary human neuroblasts. Virology 210:221–225
Esiri MM, Morris CS, Millard PR (1991) Fate of oligodendrocytes in HIV-1 infection. AIDS 5(9):1081–1088
Lackner P, Kuenz B, Reindl M, Morandell M, Berger T, Schmutzhard E, Eggers C (2010) Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study. J Neuroinflammation 7:79
Chaudhuri AD, Yelamanchili SV, Fox HS (2013) MicroRNA-142 reduces monoamine oxidase a expression and activity in neuronal cells by downregulating SIRT1. PLoS One 8(11):e79579
Zou S, Fuss B, Fitting S, Hahn YK, Hauser KF, Knapp PE (2015) Oligodendrocytes are targets of HIV-1 Tat: NMDA and AMPA receptor-mediated effects on survival and development. J Neurosci 35(32):11384–11398
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
McGee, J., Minagar, A. (2017). NeuroAIDS: A Review of Gene Expression in Neurons, Astrocytes, and Oligodendrocytes. In: Shapshak, P., et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7290-6_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7288-3
Online ISBN: 978-1-4939-7290-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)